Definium Therapeutics (DFTX) Acquisitions (2021)
Definium Therapeutics' (DFTX) quarterly Acquisitions came in at $297000.0 in Q1 2021.
Definium Therapeutics (DFTX) Acquisitions (2021) Analysis & Trends
Definium Therapeutics (DFTX) has 1 years of Acquisitions data on file, last reported at $297000.0 in Q1 2021.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $297000.0 in Q1 2021; TTM through Dec 2021 was $297000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $297000.0, changed N/A from the prior year.
- Acquisitions for Q1 2021 stood at $297000.0.
- Over the last five years, Acquisitions for DFTX reached as high as $297000.0 in Q1 2021 and fell as low as $297000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 297,000.00 |